Stock Analysis on Net
Stock Analysis on Net

Procter & Gamble Co. (NYSE:PG)

Paying users zone. Data is hidden behind: .

  • Get 1-month access to Procter & Gamble Co. for $19.99, or

  • get full access to the entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Income Statement
Quarterly Data

Beginner level

The income statement presents information on the financial results of a company’s business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Procter & Gamble Co., consolidated income statement (quarterly data)

US$ in millions

Microsoft Excel LibreOffice Calc
3 months ended: Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014
Net sales
Cost of products sold
Gross profit
Selling, general and administrative expense
Goodwill and indefinite-lived intangible asset impairment charges
Venezuela deconsolidation charge
Operating income
Interest expense
Interest income
Other non-operating income (expense), net
Earnings from continuing operations before income taxes
Income taxes on continuing operations
Net earnings from continuing operations
Net earnings (loss) from discontinued operations
Net earnings
Net earnings attributable to noncontrolling interests
Net earnings attributable to Procter & Gamble
Preferred dividends
Net earnings attributable to P&G available to common shareholders

Based on: 10-K (filing date: 2020-08-06), 10-Q (filing date: 2020-04-20), 10-Q (filing date: 2020-01-23), 10-Q (filing date: 2019-10-22), 10-K (filing date: 2019-08-06), 10-Q (filing date: 2019-04-23), 10-Q (filing date: 2019-01-23), 10-Q (filing date: 2018-10-19), 10-K (filing date: 2018-08-07), 10-Q (filing date: 2018-04-19), 10-Q (filing date: 2018-01-23), 10-Q (filing date: 2017-10-20), 10-K (filing date: 2017-08-07), 10-Q (filing date: 2017-04-26), 10-Q (filing date: 2017-01-20), 10-Q (filing date: 2016-10-25), 10-K (filing date: 2016-08-09), 10-Q (filing date: 2016-04-26), 10-Q (filing date: 2016-01-26), 10-Q (filing date: 2015-10-23), 10-K (filing date: 2015-08-07), 10-Q (filing date: 2015-04-23), 10-Q (filing date: 2015-01-27), 10-Q (filing date: 2014-10-24).

Income statement item Description The company
Net sales Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Procter & Gamble Co.’s net sales decreased from Q2 2020 to Q3 2020 but then slightly increased from Q3 2020 to Q4 2020.
Operating income The net result for the period of deducting operating expenses from operating revenues. Procter & Gamble Co.’s operating income decreased from Q2 2020 to Q3 2020 but then slightly increased from Q3 2020 to Q4 2020.
Earnings from continuing operations before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Procter & Gamble Co.’s earnings from continuing operations before income taxes decreased from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.
Net earnings attributable to Procter & Gamble The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Procter & Gamble Co.’s net earnings attributable to Procter & Gamble decreased from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.